Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Opiate-Related Disorders: early-phase trial registry
1 of 3 indexed Opiate-Related Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Opiate-Related Disorders: 3 US clinical trials tracked, 1 recruiting.
Opiate-Related Disorders is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Dimagi, running 1 of these trials.
Enrollment posture brief
Registry condition opiate-related-disorders
OPEN 1 | RECR 33% | LATE 1 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Opiate-Related Disorders lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Opiate-Related Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Opiate-Related Disorders is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Chatbot to Support Substance Use Recovery
Dimagi
NCT06845878
Starting Treatment With Agonist Replacement Therapies (START)
University of California, Los Angeles
NCT00315341
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
National Institute on Drug Abuse (NIDA)
NCT00292110
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Opiate-Related Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Opiate-Related Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Opiate-Related Disorders page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Opiate-Related Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dimagi sponsors the most Opiate-Related Disorders trials on record, review their full trial history before evaluating a specific study. See Dimagi's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opiate-Related Disorders condition card totals 3 registered trials; most-linked intervention Methadone; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.